MYGN - Myriad Genetics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MYGN is currently covered by 4 analysts with an average price target of $6.14. This is a potential upside of $4.27 (57.84%) from yesterday's end of day stock price of $3.89.

Myriad Genetics's activity chart (see below) currently has 104 price targets and 88 ratings on display. The stock rating distribution of MYGN is 71.43% HOLD and 28.57% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 65.1% with an average time for these price targets to be met of 168.3 days.

Highest price target for MYGN is $9, Lowest price target is $2, average price target is $6.14.

Most recent stock forecast was given by LU LI from UBS on 09-Sep-2026. First documented stock forecast 31-May-2013.

Currently out of the existing stock ratings of MYGN, 5 are a HOLD (71.43%), 2 are a BUY (28.57%).

Split History since 2000:

3/26/09 2 for 1

9/12/00 2 for 1

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 10-Dec-2024

$3.6

$-0.29 (-7.46%)

$6

11 days ago
(09-Sep-2026)

4/6 (66.67%)

$0.41 (12.85%)

66

Buy Since 15-May-2025

$2

$-1.89 (-48.59%)

$8.5

19 days ago
(01-Sep-2026)

0/5 (0%)

$-1.18 (-37.11%)

Hold Since 24-Feb-2026

$5.5

$-0.38 (-6.46%)

$6

4 months 14 days ago
(06-May-2026)

13/14 (92.86%)

$1.39 (33.82%)

124

Hold Since 01-Mar-2023

$9

$3.12 (53.06%)

$8

10 months 16 days ago
(04-Nov-2025)

3/7 (42.86%)

$2.54 (39.32%)

114

Hold Since 19-Sep-2024

$7

$1.12 (19.05%)

$16

1 years 4 months ago
(20-May-2025)

1/3 (33.33%)

$2.55 (57.30%)

114

Show more analysts

Please expand the browser size to see the chart

What is MYGN (Myriad Genetics) average time for price targets to be met?

On average it took 168 days for the stock forecasts to be reached, with an average price target met ratio of 65.1%.

Which analyst most recently updated their price target on MYGN (Myriad Genetics)?

Lu Li

Which analyst has the most public recommendations on MYGN (Myriad Genetics)?

Lu Li works at UBS and has 7 price targets and 4 ratings on MYGN

Which analyst is the currently most bullish on MYGN (Myriad Genetics)?

Drew Jones with the highest potential upside of $47.65

Which analyst is the currently most reserved on MYGN (Myriad Genetics)?

Dave Weiner with the lowest potential downside of -$1.89

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?